Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D and cancer.

Rajendra G. Mehta1, Rajeshwari R. Mehta

  • 1Department of Surgical Oncology, University of Illinois, College of Medicine, 840 South Wood Street (M/C 820), 60612, Chicago, IL, USA

The Journal of Nutritional Biochemistry
|May 17, 2002
PubMed
Summary

Vitamin D analogs show promise for cancer treatment, but toxicity remains a challenge. Research focuses on developing safer, more effective analogs by understanding their genomic and non-genomic actions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Disruption of Branched-chain Amino Acids Homeostasis Exacerbates MCD-induced Steatohepatitis by Amplifying a Pro-inflammatory Positive Feedback Loop between Hepatocytes and Macrophages.

The Journal of nutritional biochemistry·2026
Same journal

Ergothioneine attenuates cardiac fibrosis induced by a high-fat diet in spontaneously hypertensive rats.

The Journal of nutritional biochemistry·2026
Same journal

Adrenaline induces oxidative stress-mediated perturbation in cardiac riboflavin metabolism through direct interaction with flavin coenzymes: protection by melatonin-a mechanistic insight.

The Journal of nutritional biochemistry·2026
Same journal

Food-derived bioactive compounds in ocular diseases: molecular mechanisms, clinical evidence, and translational challenges.

The Journal of nutritional biochemistry·2026
Same journal

CYP450 Network Shifts in MASLD/MASH: From Pathogenesis to Nutrition-Informed Modulation.

The Journal of nutritional biochemistry·2026
Same journal

Dietary Exopolysaccharides Alleviate SARA-Induced Colonic Dysfunction in Hu Sheep by Modulating Microbiota and Enhancing Barrier Integrity.

The Journal of nutritional biochemistry·2026

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Vitamin D acts as a steroid hormone via its active metabolite, 1alpha, 25 dihydroxyvitamin D3 [1,25(OH)2D3].
  • 1,25(OH)2D3 binds to vitamin D receptors (VDR) with high affinity, influencing gene expression.
  • Clinical use of 1,25(OH)2D3 for cancer is limited by hypercalcemia induction.

Purpose of the Study:

  • To explore the potential of vitamin D analogs in cancer prevention and therapy.
  • To synthesize and evaluate novel vitamin D analogs for improved efficacy and reduced toxicity.
  • To elucidate the molecular mechanisms underlying vitamin D's anticancer effects.

Main Methods:

  • Synthesis and preclinical evaluation of approximately 400 structural vitamin D analogs.
  • Phase I clinical trials assessing dose tolerance of promising analogs (e.g., EB1089, RO24-5531).
  • Investigation of both genomic (VDR-mediated) and non-genomic pathways of vitamin D action.

Main Results:

  • Several less toxic, highly efficacious vitamin D analogs have been identified.
  • Early-stage clinical trials indicate potential therapeutic applications for advanced cancers.
  • Vitamin D exerts effects through nuclear VDR (genomic) and membrane-associated (non-genomic) pathways.

Conclusions:

  • Development of non-toxic vitamin D analogs is crucial for cancer therapy.
  • Understanding the dual genomic and non-genomic mechanisms is key to optimizing vitamin D-based cancer treatments.
  • Vitamin D analogs represent a developing area in cancer prevention and treatment strategies.

Related Experiment Videos